Latest Breaking News On - Wangy cepharanthine - Page 1 : comparemela.com

PharmaDrug Inc : PharmaDrug s Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine

PharmaDrug Inc : PharmaDrug s Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesZwei rohstoff chancenRobertj steenWangy cepharanthineRobert steenExperte carsten storkAustralian human research ethics committeeDrug administrationSecuredose synthetics incSairiyo therapeutics incPharmadrug incPharmather holdings ltdNewsfile corpSairiyo therapeutics australia pty ltdAustralian federal government researchSairiyo therapeutics

PharmaDrug Inc : PharmaDrug Announces Plans for First-In-Human Clinical Study with PD-001 (Enteric-Coated Cepharanthine -2HCL) in Esophageal Cancer

Toronto, Ontario (Newsfile Corp. - February 13, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development

United statesWangy cepharanthineDaniel cohenPharmadrug incDrug administrationNational cancer institute surveillanceNewsfile corpAustralia therapeutic goods administrationAustralia researchGenvion corporationAmerican cancer societyTherapeutic goods administrationEnteric coated oral cepharanthineValidated studies reveal potentialEnabling esophageal cancerSairiyo therapeutics

PharmaDrug Inc : PharmaDrug Advances Programs in Oncology with Filing of PCT Application Detailing the Use of PD-001 for Treatment of Prostate Cancer

Toronto, Ontario (Newsfile Corp. - January 31, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development

United statesWangy cepharanthineDaniel cohenBaillyc cepharanthineNewsfile corpDevelopment paths for oncologyPharmadrug incDrug administrationPatent cooperation treatySet forthCentered around demonstrated benefitPre clinical prostate cancerProvisional patentValidated studies support potentialDevelopment pathsInfectious disease create

PharmaDrug Advances Programs in Oncology and Infectious Disease Through Completion of cGMP Drug Substance Manufacturing

PharmaDrug Advances Programs in Oncology and Infectious Disease Through Completion of cGMP Drug Substance Manufacturing
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSouth africaJapan generalSouth africanWangy cepharanthineDaniel cohenBaillyc cepharanthineNewsfile corpDevelopment paths for oncologyPharmadrug incDrug administrationGenvion corporationDevelopment pathsInfectious disease createEnteric coated oral cepharanthineValidated studies reveal potential

PharmaDrug Inc : PharmaDrug Successfully Completes Key Milestone to Support cGMP Production of Clinical Lead Candidate PD-001, Its Patented, Orally Available Version of Cepharanthine for Oncology and Infectious Disease

Completes qualification of all necessary analytical methodologies to support production of Cepharanthine-2HCL drug substanceClinical trial-scale production of cGMP Cepharanthine-2HCL drug substance scheduled

United statesSouth africaJapan generalSouth africanWangy cepharanthineDaniel cohenBaillyc cepharanthineNewsfile corpDevelopment paths for oncologyPharmadrug incDrug administrationGenvion corporationDevelopment pathsInfectious disease createEnteric coated oral cepharanthineValidated studies reveal potential